Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G G Chabot

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Biochemical Pharmacology|April 1, 1983
Kinetics of deamination of 5-aza-2'-deoxycytidine and cytosine arabinoside by human liver cytidine deaminase and its inhibition by 3-deazauridine, thymidine or uracil arabinosideG G Chabot, J Bouchard, R L Momparler
Molecular Pharmacology|November 28, 2000
Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolitesJ Marill, T Cresteil, M Lanotte, et al.
Cancer Research|February 1, 1983
Plasma and cerebrospinal fluid pharmacokinetics of 5-Aza-2'-deoxycytidine in rabbits and dogsG G Chabot, G E Rivard, R L Momparler
Bulletin Du Cancer|February 5, 1999
[Irinotecan pharmacokinetics]G G Chabot, J Robert, F Lokiec, et al.
Annals of the New York Academy of Sciences|December 13, 1996
Preclinical antitumor activity and pharmacokinetics of irinotecan (CPT-11) in tumor-bearing miceM C Bissery, P Vrignaud, F Lavelle, et al.
Anti-Cancer Drugs|June 1, 1996
Experimental antitumor activity and pharmacokinetics of the camptothecin analog irinotecan (CPT-11) in miceM C Bissery, P Vrignaud, F Lavelle, et al.
Biochemical Pharmacology|June 14, 1996
In vivo induction of cytochrome P450 CYP3A expression in rat leukocytes using various inducersA Mahnke, P H Roos, W G Hanstein, et al.
Journal of Pharmaceutical Sciences|April 1, 1989
Pharmacokinetics and toxicity of continuous infusion amphotericin B in cancer patientsG G Chabot, R Pazdur, F A Valeriote, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Alteration of dacarbazine pharmacokinetics after interleukin-2 administration in melanoma patientsG G Chabot, L E Flaherty, M Valdivieso, et al.
Cancer Research|February 24, 2001
Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolitesN Idres, G Benoît, M A Flexor, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Biochemical Pharmacology|April 1, 1983
Kinetics of deamination of 5-aza-2'-deoxycytidine and cytosine arabinoside by human liver cytidine deaminase and its inhibition by 3-deazauridine, thymidine or uracil arabinosideG G Chabot, J Bouchard, R L Momparler
Molecular Pharmacology|November 28, 2000
Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolitesJ Marill, T Cresteil, M Lanotte, et al.
Cancer Research|February 1, 1983
Plasma and cerebrospinal fluid pharmacokinetics of 5-Aza-2'-deoxycytidine in rabbits and dogsG G Chabot, G E Rivard, R L Momparler
Bulletin Du Cancer|February 5, 1999
[Irinotecan pharmacokinetics]G G Chabot, J Robert, F Lokiec, et al.
Annals of the New York Academy of Sciences|December 13, 1996
Preclinical antitumor activity and pharmacokinetics of irinotecan (CPT-11) in tumor-bearing miceM C Bissery, P Vrignaud, F Lavelle, et al.
Anti-Cancer Drugs|June 1, 1996
Experimental antitumor activity and pharmacokinetics of the camptothecin analog irinotecan (CPT-11) in miceM C Bissery, P Vrignaud, F Lavelle, et al.
Biochemical Pharmacology|June 14, 1996
In vivo induction of cytochrome P450 CYP3A expression in rat leukocytes using various inducersA Mahnke, P H Roos, W G Hanstein, et al.
Journal of Pharmaceutical Sciences|April 1, 1989
Pharmacokinetics and toxicity of continuous infusion amphotericin B in cancer patientsG G Chabot, R Pazdur, F A Valeriote, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Alteration of dacarbazine pharmacokinetics after interleukin-2 administration in melanoma patientsG G Chabot, L E Flaherty, M Valdivieso, et al.
Cancer Research|February 24, 2001
Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolitesN Idres, G Benoît, M A Flexor, et al.
Pageof 6